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a  b  s  t  r  a  c  t
One  of  the  big  surprises  about  the  devastating  outbreak  of  bluetongue  serotype-8  that spread  across
Northern  and  Western  Europe  between  2006  and  2008  was  how  relatively  quickly  the  virus  was  con-
trolled  and  eradicated  from  affected  countries.  This  was  at least  in part  attributed  to  the  high  levels  of
vaccine  coverage  achieved  in affected  countries.  A  previous  study  revealed  that  neutralising  antibodieseywords:
luetongue
nactivated vaccines
umoral response
rotection
persisted  in  the majority  of vaccinated  cattle  for at least 3 years  post-vaccination,  indicating  that cattle
are  likely  to be protected  for this  time  period.  The  current  study  revealed  that  neutralising  antibodies
persisted  in  the same  group  of  cattle  for up to 4  years  post-vaccination,  and  that  neutralising  antibodies
persisted  for  up  to 2.5 years  in  sheep  that had  been  vaccinated  on  two occasions  one  year  apart.  These
results  have  implications  for future  bluetongue  surveillance  programmes  and  vaccine  control  strategies.
 2013  ©
. Introduction
The vaccination campaigns, using inactivated vaccines against
luetongue serotype-8 (BTV-8), were highly successful in control-
ing and eradicating BTV-8 from affected countries in Northern and
estern Europe. This was despite some countries using voluntary
accination campaigns and other countries reverting from compul-
ory to voluntary vaccine campaigns after one or two years, which
esulted in some farmers choosing not to revaccinate their livestock
n the second and third years of the outbreak [1]. The reduced vac-
ine coverage that ensued resulted in experts fearing a resurgence
f the virus. However, despite the reduced levels of vaccine cover-
ge in some countries in the second and third year of the outbreak,
he amount of cases of BTV-8 reported across Europe continued to
ecrease dramatically, with no cases of BTV-8 reported in Northern
nd Western Europe in 2010. By 2012 most countries in Northern
nd Western Europe had successfully eradicated BTV-8 from their
erritories [2].
The commercially available BTV-8 inactivated vaccines have
hown good safety and efﬁcacy in both cattle and sheep, and
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studies have shown that both sheep and cattle are protected for
at least 1 year post-vaccination [3–8]. A recent study revealed that
group-speciﬁc antibodies persisted at high levels in milk and serum
in a high percentage of cattle for at least 3 years post-vaccination,
thus removing the option of using these animals in ELISA-based
surveillance programmes. The same study showed that neutralising
antibodies persisted in a high percentage of cattle for at least 3 years
post-vaccination, indicating that cattle are likely to be protected for
this time period [9].
The objectives of this study were to follow up on the previous
study [9] and to assess the status of the humoral immune response
in the same group of adult cattle 4 years after the initial course
of BTV-8 vaccination. The study also assessed the status of the
humoral immune response in a group of adult sheep 2.5 years after
a second BTV-8 vaccination, given 1 year after the primary vacci-
nation. This will provide information on the length of persistence
of antibodies post-vaccination in the blood and milk for surveil-
lance purposes, as well as the persistence of neutralising antibodies,
which is likely to be linked to protection.
2. Materials and methods
Open access under CC BY license.2.1. Cattle and experimental design
Twenty-nine adult Friesian–Holstein cattle from a dairy farm
in the county of Surrey, UK, that had been previously sampled
license. 
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nd tested for antibodies to BTV in both milk and serum [9], were
elected for resampling in this study. These cattle were considered
ot to have been naturally infected with BTV-8 during the BTV-8
utbreak in the UK in 2007 due to the fact that no clinical cases
f BT were conﬁrmed in the county of Surrey throughout 2007,
nd no further cases of BTV-8 were declared in the UK between
008 and 2011 [9]. The cattle were vaccinated by sub-cutaneous
njection in the neck region on two occasions, 4 weeks apart
according to the manufacturer’s instructions) in May  and June
008 with the Intervet-manufactured Bovilis-BTV-8 (Intervet,
ermany) inactivated vaccine. The cattle were not revaccinated
etween 2009 and 2012.
The 29 cattle were sampled in June 2012. Whole blood (serum)
amples and individual milk samples were collected, unfortunately
 milk sample was not collected from one animal. These 29 cattle
ad been previously tested for the presence of BTV antibodies in
011 [9].
.2. Sheep and experimental design
Twenty-three adult sheep of mixed breeds from a farm in
urrey, UK were selected for the study. The sheep were vaccinated
y sub-cutaneous injection in the neck region with a single dose
according to the manufacturer’s instructions) on two occasions in
ay  2008 and again in May  2009 with the Intervet-manufactured
ovilis-BTV-8 (Intervet, Germany) inactivated vaccine. The sheep
ere not revaccinated between 2010 and December 2011. Whole
lood (serum) samples were collected from the 23 sheep in
ecember 2011.
able 1
ersistence of antibodies, measured by ELISA and SNT, in the milk and blood of adult dair
Cow number Milk ELISA (%S/P)a Early de
2011 2012 2011 
1 Pos (290) Pos (153) Pos (184
2  Pos (221) Neg (79) Pos (184
3  Pos (262) Pos (142) Pos (165
4  Neg (68) Neg (24) Pos (178
5  Pos (307) No sample Pos (193
6  Pos (305) Pos (144) Pos (190
7  Pos (206) Pos (134) Pos (193
8  Pos (140) Pos (113) Pos (193
9  Pos (301) Pos (145) Pos (183
10  Pos (295) Pos (146) Pos (192
11  Pos (292) Pos (146) Pos (122
12  Pos (189) Pos (125) Pos (153
13  Pos (281) Pos (131) Pos (193
14  Pos (286) Pos (139) Pos (170
15  Pos (229) Pos (125) Pos (183
16  Pos (298) Pos (152) Pos (187
17  Pos (304) Pos (148) Pos (193
18  Pos (300) Pos (137) Pos (185
19  Inc (98) Neg (68) Pos (165
20  Pos (241) Pos (141) Pos (193
21  Pos (247) Pos (124) Pos (191
22  Pos (260) Pos (114) Pos (193
23  Pos (306) Pos (150) Pos (193
24  Pos (306) Pos (153) Pos (189
25  Pos (301) Pos (151) Pos (187
26  Neg (7) Neg (-8) Neg (22
27  Neg (52) Pos (135) Pos (176
28  Neg (50) Neg (58) Pos (107
29  Pos (268) Pos (137) Pos (181
NT: serum neutralisation test; Pos: positive; Neg: negative; Inc: inconclusive.
 S/P: percentage of positivity compared to the positive control.
old value shows the negative results.
a Individual samples: negative ≤90%, inconclusive 90–110%, positive ≥110%.
b Negative ≤25%, inconclusive 25–30%, positive ≥30%.1 (2013) 3783– 3785
2.3. Serology
2.3.1. ELISA
The detection of BTV speciﬁc antibodies in serum was carried
out using a sandwich (double antigen) ELISA (sELISA, ID-Screen
Bluetongue Early detection ELISA, ID-Vet, France) according to the
manufacturer’s instructions. The detection of BTV speciﬁc antibod-
ies in milk was carried out using the ID Screen® Bluetongue Milk
ELISA (ID-Vet, France) according to the manufacturer’s instructions.
2.3.2. Serum neutralisation test (SNT)
SNT was performed according to the method of Haig [10] using
the BTV-8 South African reference virus and serotype-speciﬁc BTV-
8 positive control antisera [9].
3. Results
3.1. Cattle 4 years post vaccination
A group of 29 adult dairy cattle, that had been given two  shots of
inactivated BTV-8 vaccine 4 weeks apart in May/June 2008 and had
not been revaccinated since, were sampled 4 years after the primary
course of vaccination in June 2012. Serum samples were tested for
the presence of group speciﬁc BTV antibodies by a sELISA and for
the presence of type-speciﬁc neutralising antibodies to BTV-8 by
SNT. Individual milk samples were tested for the presence of group-
speciﬁc BTV antibodies by ELISA. From the 29 serum samples, 28
(97%) were positive in the sELISA and SNT, with neutralising titres
ranging from log10 1–2.38. Twenty-three of the 28 individual milk
samples (82%) were positive for BTV antibodies in ELISA (Table 1).
y cattle four years post-vaccination with a BTV-8 inactivated vaccine.
tection ELISA (%S/P)b SNT log10
2012 2011 2012
) Pos (254) Pos (1.18) Pos (1.48)
) Pos (251) Pos (1.48) Pos (1.00)
) Pos (267) Pos (1.78) Pos (1.78)
) Pos (224) Pos (1.60) Pos (1.48)
) Pos (280) Pos (1.00) Pos (1.78)
) Pos (255) Pos (2.38) Pos (2.20)
) Pos (267) Pos (1.60) Pos (2.20)
) Pos (280) Pos (2.20) Pos (1.78)
) Pos (262) Pos (1.78) Pos (1.78)
) Pos (255) Pos (2.08) Pos (2.38)
) Pos (185) Pos (1.60) Pos (1.90)
) Pos (230) Pos (1.18) Pos (1.60)
) Pos (280) Pos (1.48) Pos (1.18)
) Pos (240) Pos (1.18) Pos (1.60)
) Pos (264) Pos (1.18) Pos (1.00)
) Pos (266) Pos (1.78) Pos (2.08)
) Pos (266) Pos (1.30) Pos (1.78)
) Pos (268) Pos (2.51) Pos (1.90)
) Pos (198) Pos (1.00) Pos (1.18)
) Pos (276) Pos (1.30) Pos (1.48)
) Pos (262) Pos (1.48) Pos (1.18)
) Pos (240) Pos (1.60) Pos (1.60)
) Pos (270) Pos (1.78) Pos (1.78)
) Pos (268) Pos (1.00) Pos (1.18)
) Pos (269) Pos (1.48) Pos (1.60)
) Neg (18) Neg Neg
) Pos (263) Pos (1.18) Pos (1.18)
) Pos (99) Pos (1.30) Pos (1.78)
) Pos (248) Pos (1.60) Pos (1.60)
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Table 2
Persistence of antibodies, measured by ELISA and SNT, in the blood of sheep 2.5
years post-vaccination (2 vaccines given one year apart) with a BTV-8 inactivated
vaccine.
Animal number Early detection ELISA (%S/P)a SNT log10
1 Pos (242) Pos (1.90)
2  Pos (256) Pos (1.78)
3  Pos (231) Pos (1.48)
4  Pos (256) Pos (1.90)
5  Pos (231) Pos (1.48)
6  Pos (249) Pos (2.20)
7  Pos (261) Pos (1.60)
8  Pos (241) Pos (2.08)
9  Pos (242) Pos (2.08)
10  Pos (244) Pos (1.60)
11  Pos (181) Pos (1.78)
12  Pos (253) Pos (1.90)
13  Pos (194) Pos (2.08)
14  Pos (251) Pos (1.30)
15  Pos (239) Pos (1.60)
16  Pos (247) Pos (1.60)
17  Pos (252) Pos (2.38)
18  Pos (254) Pos (2.20)
19  Pos (229) Pos (1.60)
20  Pos (268) Pos (2.08)
21  Pos (232) Pos (2.08)
22  Pos (216) Pos (2.38)
23  Pos (231) Pos (1.78)
SNT: serum neutralisation test; Pos: positive; Neg: negative; Inc: inconclusive.
%  S/P: percentage of positivity compared to the positive control.
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2004. p. 1201–20.a Negative ≤25%, inconclusive 25–30%, positive ≥30%.
.2. Sheep 2.5 years post vaccination
A group of 23 adult sheep, that had been vaccinated with inactiv-
ted BTV-8 vaccine in May  2008 and 2009 and had not been
evaccinated since, were sampled after 2.5 years in December 2011.
erum samples were tested for the presence of group speciﬁc BTV
ntibodies by a sELISA and for the presence of type-speciﬁc neu-
ralising antibodies to BTV-8 by SNT. From the 23 serum samples,
3 (100%) were positive in the sELISA and SNT, with neutralising
itres ranging from log10 1.30–2.38 (Table 2).
. Discussion
One of the big surprises related to the devastating outbreak of
TV-8 that spread across Northern and Western Europe between
006 and 2008, was how relatively quickly the virus was controlled
nd eradicated from affected countries. The principal contribut-
ng factor was likely to be related to the high levels of natural
nd vaccine-related immunity present in the susceptible ruminant
opulations throughout the affected regions. In many European
ountries that were affected by the virus, a high percentage of sus-
eptible ruminants were naturally infected during the outbreak.
 recent study showed that high levels of neutralising antibod-
es were induced in naturally infected cattle for four to six years
fter the last exposure to BTV-8, indicating that naturally infected
nimals are likely to remain protected for many years [11].
A key question that remained unaddressed was for how long cat-
le and sheep were likely to be protected for after vaccination with
he inactivated BTV-8 vaccines on the market. A previous study [9],
evealed that neutralising antibodies persisted in the majority of
accinated cattle for at least 3 years post-vaccination, indicating
hat the cattle are likely to be protected for this time period. The
ame authors have now revealed that neutralising antibodies per-
isted in the same group of cattle for up to 4 years post-vaccination,
nd that neutralising antibodies persisted for up to 2.5 years in
heep that had been vaccinated on two occasions one year apart.
[1 (2013) 3783– 3785 3785
Neutralising antibodies are known to play a key role in protecting
animals from disease and viraemia and there is known to be a strong
correlation between the presence of neutralising antibodies and
protection [4,12–14]. These results therefore indicate that cattle
are likely to be protected for at least 4 years after the initial course
of two vaccines, and that sheep, provided they are vaccinated on
two occasions one year apart, are likely be protected for at least
2.5 years after the second vaccination. There is however a need to
conﬁrm this protection through challenge studies.
These results have implications for future bluetongue surveil-
lance and control programmes in that group-speciﬁc antibodies in
both individual and bulk milk samples, as well as serum samples,
persist in the majority of vaccinated cattle for at least 4 years, and in
sheep for at least 2.5 years, thus precluding the use of these tests for
surveillance purposes during this time period. It would however be
possible to carry out surveillance using younger cattle/sheep that
had not been vaccinated. The results also reveal that BTV inactiv-
ated vaccines may produce far longer periods of immunity in cattle
and sheep than originally thought, which may  have contributed
to the rapid and efﬁcient eradication of BTV-8 from Northern and
Western Europe, despite reduced vaccination coverage in the 2nd
and 3rd year of the outbreak.
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